Angel Nutritech has a new leader, with Zhou Chenpeng taking over from Tan Rongxin, marking a shift from concept incubation to hard-core monetization amid supply and profitability pressures.
Angel Yeast's core health flagship, Angel Nutritech Co., Ltd., a veteran biotechnology giant, recently underwent a significant top-level industrial and commercial change. Tan Rongxin, who had been at the helm for an extended period and guided the brand through a critical growth phase, officially stepped down as the company's legal representative, chairman, and general manager, with Zhou Chenpeng taking over all of these roles.
This synchronized handover at the top comes at a particularly intriguing moment, right after Angel Yeast released its 2025 annual results, which showed revenue exceeding 16.7 billion yuan and a sharp increase in net profit. In the eyes of outsiders, Angel Nutritech, backed by state capital and the yeast industry leader, is riding a wave of smooth trial sales for new products, and many retail investors have interpreted this leadership change as a normal rotation of the executive pipeline within a state-owned enterprise. However, this shallow view, which lacks an industry perspective, completely overlooks the near-suffocating profit pressure and long-term defensive demands that Angel Yeast is imposing on its second growth curve as its traditional baking business reaches its ceiling and raw material costs such as upstream molasses experience sharp fluctuations.
A Heavyweight Armored Force with a 100 Million Yuan Base: Examining the Real Foundation Through Tianyancha
This is by no means a lightweight asset-light marketing shell focused only on selling white-label probiotics or multivitamins through livestreams. According to the underlying corporate profile disclosed by Tianyancha, Angel Nutritech Co., Ltd. was established in April 2020 with a registered capital of 100 million yuan. In Tianyancha's equity penetration chain, the company's shareholder roster is firmly locked down by Angel Yeast Co., Ltd. and Angel Yeast (Binzhou) Co., Ltd., ensuring 100% absolute state-controlled ownership.
This heavy 100 million yuan capital base, as reflected in Tianyancha's system, covers an extremely broad and hardcore scope of business operations, including the production and omni-channel sales of food, condiments, and beverages. Behind these cold industrial and commercial data points lies the full portfolio of core technological assets that Angel Yeast is deploying in support of the national strategies for a broader concept of food and bio-manufacturing. In recent years, although the traditional baking yeast market has remained among the top globally, friction in the global supply chain and slowing growth in the traditional food processing industry mean that merely selling basic yeast powder can no longer support the valuation narrative of this trillion-level bio-empire. What Angel Nutritech carries on its shoulders is the special forces mission of achieving pixel-level commercial deployment of high-margin new food ingredients such as yeast protein and glutathione-enriched yeast.
From Incubation to Harvest: Tan Rongxin's Exit and Zhou Chenpeng's Price Battle
Once this chain of interests is clarified, it becomes clear that the legal handover of authority between Tan Rongxin and Zhou Chenpeng is essentially a cold signal that Angel Nutritech is shifting from the concept seeding phase to a hardcore harvesting phase.
During Tan Rongxin's tenure, Angel Nutritech completed its initial breakthrough from yeast functional ingredients to retail dietary vitamin and dietary supplement (VDS) products. They not only launched children's growth formula milk powder but also successfully integrated "yeast protein," the first new food ingredient of its kind in China, into the supply chains of sports nutrition and health foods for middle-aged and elderly consumers. But now, entering 2026, the domestic dietary supplement market is no longer the blue ocean it once was; it has fallen into a price meat grinder woven together by By-Health, multinational giants, and a flood of cross-border white-label brands. In a cycle where omni-channel traffic costs remain high and consumers have become extremely rational, hollow technical presentations are no longer enough to get long-tail consumers to keep paying a premium.
New leader Zhou Chenpeng is stepping onto the stage, but what he is taking over is by no means a safe caretaker's ticket. In this year's strategic deliberations, Angel Yeast has welded cost reduction, supply assurance, quality improvement, and compliance into the capillaries of all its subsidiaries. Zhou Chenpeng's true mission is to take the hardcore biotech that has passed the U.S. SA-GRAS certification in the lab and drive it with thunderous force into the most down-to-earth markets: customized seasoning for restaurant chains, meal replacements for middle-aged and elderly consumers, and clean-label food products. Through the most rigorous lean production and cost control capabilities, he must squeeze out substantial real profits for the parent company on every gram of yeast protein peptide margin.
The evolution of business has always been cold and ruthless. In this brutal cycle where true cash-generation efficiency and channel control determine ultimate survival sovereignty, marginal sub-sectors that rely purely on telling biotech stories without achieving large-scale industrial payback will ultimately face liquidation in headquarters' drive to cut fat and increase muscle. This line of sovereignty change that Angel Nutritech has written into Tianyancha is the most pragmatic memorandum for a major manufacturing player at a technological inflection point. Whoever can first set aside the scientist's aloofness and stitch together cold, foundational cell technology with the muddiest consumer demand in lower-tier markets will be the one who, in the coming shakeout of existing capacity, can truly tighten the safety lifeline that ensures the asset's perpetual cash generation.
